申请人:Janssen Pharmaceutica NV
公开号:US20170044148A1
公开(公告)日:2017-02-16
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (III) as follows:
wherein R
1C
, R
2C
, R
4C
, W
C
, Y
C
, Z
C
, and G
C
, are defined herein.